Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
Stock Information for Odyssey Group Intl Inc
Loading
Please wait while we load your information from QuoteMedia.